Orphan Drugs Market Size, Global Insights, Segmentation and Forecast till 2025 | Fortune Business Insights

Orphan Drugs Market was worth US$ 67,136.0 Mn in 2017 and will continue to rise at a steady pace until 2025.This is further helping the orphan drugs market to grow impressively in various regions

Pune, India - May 15, 2019 /MarketersMedia/ —

As per Fortune Business Insights, the North America Orphan Drugs Market was worth US$ 67,136.0 Mn in 2017 and will continue to rise at a steady pace until 2025. This is mainly ascribable to the rising awareness among people regarding the use of novel drugs. In addition to this, North America is expected to offer attractive growth opportunities on the back of recent FDA approvals on the development of orphan drugs.

Governments in North America are increasingly spending on research and development (R&D) of orphan drugs and technologies. This is further helping the orphan drugs market to grow impressively in this region. Asia Pacific, on the other hand, is anticipated to show a higher rate of growth on account of the rising prevalence of rare diseases such as chronic lymphocytic leukemia. Also, the region is expected to offer lucrative growth opportunities as a result of the rapid expansion of healthcare infrastructure.

Request Sample Copy at https://www.fortunebusinessinsights.com/enquiry/sample/orphan-drugs-market-100088

North America is expected to remain dominant in the Global Orphan Drugs Market between 2018 and 2025. This information was found by Fortune Business Insights in a report, titled “Orphan Drugs Market: Global Market Analysis, Insights and Forecast, 2018-2025”. According to the report, the Global Orphan Drugs Market was valued at US$ 125000 Mn in 2017 and is anticipated to reach US$ 294000 Mn by 2025. The report also stated that the market will exhibit a remarkable CAGR of 11.4% during the forecast period.

Rising Prevalence of Cancer and Related Diseases Fuels Demand for Orphan Drugs

The oncology segment is witnessing considerably high demand on account of the rising number of patients suffering from different types of cancers. This also increases the demand for novel therapeutics, which as per the report will bode well for the global orphan drugs market. According to the National Center for Health Statistics, the U.S. is likely to witness around 1,762,450 new cancer cases in 2019. Spurred by these numbers, the demand for orphan drugs is likely to increase in the coming years. Governments are investing heavily to build a strong framework for supporting drug development, thus offering a significant impetus to the orphan drugs market. Furthermore, the return on investment, with regards to orphan drugs, is expected to be higher than non-orphan drugs, which in turn is increasing the demand for orphan drug therapeutics worldwide.

“People across the world are becoming more aware about the rising prevalence of rare disorders and importance of orphan drugs,” stated a lead analyst at Fortune Business Insights. “This, coupled with robust support from EU and FDA to drug development, drives the orphan drugs market,” he added. Several pharma companies are also putting continuous efforts to develop orphan drugs, thus improving creating scope for generating more revenue in the overall global market for orphan drugs.

Browse Complete Report Details at https://www.fortunebusinessinsights.com/industry-reports/orphan-drugs-market-100088

Treatment and Medications Associated with Rare Diseases Are Expensive, Limiting Growth of Orphan Drugs Market

Although the orphan drugs market is growing at a good pace, there are some factors that may hinder its growth. The high cost of orphan drugs, insufficient information on rare diseases, and lack of skilled healthcare professionals are factors restricting growth in the global orphan drugs market. In addition to this, rising competition from generic industries may pose a serious threat to the growth of the market.

Emergence of New Players to Drive the Orphan Drug Market and Increase Competition

The global orphan drugs market is anticipated to pave way for the entry of several new players in the coming years. This is mainly because of rapid drug development and discovery over the years. Several leading companies are manufacturing orphan drugs to build a nimble and agile framework.

Some of the savvy players present in the global orphan drugs market are Actelion Pharmaceuticals Ltd., Biogen, Eli Lilly and Company, Bayer AG, Amgen Inc., and Pfizer Inc. These leading players are likely to give tough competition to the small entrants. Therefore, these small scale companies may need support from governments and other authorities to sustain in the market.

The global orphan drugs market can be segmented into the following categories:

Global Orphan Drugs Market, by Therapy Area
Oncology
Blood
CNS
Endocrine
Cardiovascular
Respiratory
Immunomodulators
Others

Global Orphan Drugs Market, by Distribution Channels
Hospital Pharmacy
Retail Pharmacy
Online Sales
Others

Global Orphan Drugs Market, by Region
North America
U.S.
Canada

Europe
Germany
U.K.
France
Italy
Spain
Scandinavia
Rest of Europe

Asia Pacific
China
India
Japan
Australia
Southeast Asia
Rest of Asia Pacific
Rest of the World

Get Discount at https://www.fortunebusinessinsights.com/enquiry/check-discount/orphan-drugs-market-100088

About us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Info:
Name: Fortune Business Insights
Email: Send Email
Organization: Fortune Business Insights
Address: Fortune Business Insights Pvt. Ltd. 308, Supreme Headquarters, Survey No. 36, Baner, Pune-Bangalore Highway, Pune - 411045, Maharashtra, India.
Phone: +1 424 253 0390
Website: https://www.fortunebusinessinsights.com

Source URL: https://marketersmedia.com/orphan-drugs-market-size-global-insights-segmentation-and-forecast-till-2025-fortune-business-insights/512968

Source: MarketersMedia

Release ID: 512968

More Press Releases

Without Messi, Barcelona loses 1st league opener in 10 years

Aug 17, 2019

MADRID — Barcelona lost its opening Spanish league match for the first time in a decade on Friday, falling at Athletic Bilbao 1-0 as Antoine Griezmann couldn't make up for Lionel Messi's absence. Veteran striker Aritz Aduriz scored from a spectacular overhead kick a minute after coming off the bench in the 88th minute, handing Barcelona the loss after 10 straight opening league wins. Griezmann, Barcelona's biggest offseason signing, was held scoreless in his competitive debut after joining from rival Atlético Madrid for 120 million euros ($133 million). It was a lackluster performance for the France forward whose only significant...

Eataly severs ties with Mario Batali amid misconduct scandal

Aug 17, 2019

NEW YORK — Chef Mario Batali, whose career crumbled amid sexual misconduct allegations, no longer owns a stake in Eataly, the Italian marketplaces he once heavily promoted. Chris Giglio, a spokesman for Eataly USA, told The Associated Press on Friday the company has purchased Batali's minority interest, formally ending the relationship. Batali has had no direct involvement with Eataly since December 2017, Giglio said. Batali, known for his orange Crocs and ponytail, has pleaded not guilty to a charge that he forcibly kissed and groped a woman at a Boston restaurant in 2017. The next court hearing in the case...

Sister: Earnhardt Jr. 'safe' after plane crash in Tennessee

Aug 17, 2019

ELIZABETHTON, Tenn. — Dale Earnhardt Jr. is "safe" and in a hospital for evaluation after his plane crashed in east Tennessee, the NASCAR television analyst and retired driver's sister tweeted. Earnhardt's sister, Kelley Earnhardt Miller, tweeted that the driver's wife, Amy, and 15-month-old daughter, Isla, also were on the plane along with two pilots. "Everyone is safe and has been taken to the hospital for further evaluation," she tweeted. "We will have no further information at this time." Federal Aviation Administration officials said a Cessna Citation rolled off the end of a runway and caught fire after landing at Elizabethton...

Aretha Franklin's cancer doctors recall her grace, grit

Aug 17, 2019

DETROIT — Regardless of her reputation as a performer, Aretha Franklin 's cancer doctors say she was no diva as a patient. As the anniversary of her death approaches, two of her doctors tell The Associated Press that the Queen of Soul handled the diagnosis and treatment with grace — and the grit to keep performing for years with a rare type of cancer. "As a person, she was extremely kind, she was respectful, she was funny — she treated people like me and my team members as her friends," said Dr. Manisha Shah of Ohio State University. "There is...

CMA voters deciding whether to nominate 'Old Town Road'

Aug 17, 2019

NASHVILLE, Tenn. — Rapper Lil Nas X's "Old Town Road" with Billy Ray Cyrus has created a musical phenomenon, but many in Nashville are trying to decide whether to nominate it for a country music award. Voting is underway for nominations for the Country Music Association Awards. "Old Town Road" faces an uphill challenge. Hit songwriter and producer Shane McAnally says most people in the country music industry do not consider it a country song. Billboard removed the song from the country charts early on, but it made enough of an impact that it became eligible anyway. Non-country artists have...

Broaden News

Reporter Pass is the only access you need to get into Hollywood. No matter it’s the red carpet event or backstage access, we’ve got you covered.

Contact us: sales@reppass.com

Award ShowsCelebrityPaparazziRoyaltyMoviesMusicTelevision Programs Press Releases